Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113183 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xing-Zhi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Fecal Microbiota Transplantation, Ovalbumin, Gastrointestinal Microbiome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Children all over the world suffer from atopic dermatitis (AD), a prevalent condition that impairs their health. Corticosteroids, which have long-term negative effects, are frequently used to treat AD. There has been a growing body of research on the gut microbiota's function in AD. Nevertheless, the function and underlying mechanisms of fecal microbiota transplantation (FMT) in AD children remain to be established. Therefore, in order to assess the preventive effects of FMT treatment on AD and investigate the mechanisms, we constructed an ovalbumin (OVA)-induced juvenile mouse AD model in this investigation. This study explored the role and mechanism of FMT treatment in AD through 16S RNA sequencing, pathological histological staining, molecular biology, and Flow cytometry. Results demonstrated that the FMT treatment improved the gut microbiota's diversity and composition, bringing it back to a level similar to that of a close donor. Following FMT treatment, OVA-specific antibodies were inhibited, immunoglobulin (Ig) E production was decreased, the quantity of mast cells and eosinophils was decreased, and specific inflammatory markers in the skin and serum were decreased. Further mechanistic studies revealed that FMT treatment induced CD103+ DCs and programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) expression in skin-draining lymph nodes and promoted Treg production to induce immune tolerance and suppress skin inflammation. Meanwhile, changes in the gut microbiota were substantially correlated with Th2 cytokines, OVA-specific antibodies, and PD-L1/PD-1. In conclusion, FMT regulates the Th1/Th2 immunological balance and the gut microbiota. It may also inhibit AD-induced allergy responses through the PD-L1/PD-1 pathway, and providing a unique idea and possibly a fresh approach to the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
- Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China. Electronic address: Huisu2014@163.com.
- Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China. Electronic address: sunxin6@fmmu.edu.cn.
Zitieren
APA
Wang, X. Z., Huang, J. L., Zhang, J., Li, Q. H., Zhang, P. P., Wu, C., Jia, Y. Y., Su, H., & Sun, X. (2024). Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113183
Vancouver
Wang XZ, Huang JL, Zhang J, Li QH, Zhang PP, Wu C, et al. Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113183
BibTeX
@article{Wang2024,
author = {Wang, Xing-Zhi and Huang, Jin-Li and Zhang, Juan and Li, Qiu-Hong and Zhang, Pan-Pan and Wu, Cheng and Jia, Yuan-Yuan and Su, Hui and Sun, Xin},
title = {Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113183}
}
EUVIMED